Ichnos Glenmark files US FDA application for solid tumour drug
Ichnos Glenmark Innovation (IGI), the biotechnology joint venture of Glenmark Pharmaceuticals and Ichnos Sciences, has submitted an investigational new drug (IND) application to the US FDA for ISB 2301, a candidate designed…






































Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.